200-Patient study aims to unlock secrets of rare bone disease
NCT ID NCT07569731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the medical records of over 200 people with fibrous dysplasia, a rare bone condition that causes abnormal growths. Researchers want to learn more about the disease's features, treatments, and genetic causes. No new treatments are being tested; the goal is simply to gather information to better understand the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROUS DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Istituto Ortopedico Rizzoli
RECRUITINGBologna, BO, 40136, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom 3D-Printed titanium implants could rebuild faces after injury or surgery
- New computer model aims to predict fractures in rare bone disorder patients
- Scientists probe mysterious bone pain in rare disorder
- Experimental drug aims to fix Bone-Weakening phosphate problem in rare disease
- Could a bone drug halt skeletal damage in kids with rare disease?
- Brain scans seek clues to mysterious bone pain